Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LuminoMark vs Charcotrace for Nonpalpable Breast Lesion Localization
NCT04606329Phase 3Completed
- Sponsor
- Hanlim Pharm
- Start
- Jul 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indocyanine green + hyaluronic acid in breast lesion, sponsored by Hanlim Pharm. Started Jul 2020; status: completed.
02
Drugs
indocyanine green + hyaluronic acid
03
Conditions
breast lesion
Beyond the preview
Go deeper on NCT04606329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04606329.